Read more at: #Bioglutide To view or add a comment, sign in Where GLP-1 meets GIP: Mounjaro (Tirzepatide) is Redefining Metabolic Care: A Landmark Innovation in Therapeutics: Mounjaro (Tirzepatide) isn't just another incretin therapy, it's the first-in-class dual GIP and GLP-1 receptor agonist approved, representing a paradigm shift in managing type 2 diabetes and beyond
The price can be high, and its important to understand what makes up the total cost
No refrigeration concerns like those discussed in our tirzepatide refrigeration guide
For the maximum dose: 2,400mcg / 2,500mcg/mL x 100 = 96 units within a 1mL syringe
Our study also indicates that liver-targeted TR agonists could be tested for the treatment of type 2 diabetes in the future
If you experience severe pain, persistent hardness, or significant swelling at an injection site that does not improve within one week, contact your PlexusDx provider immediately